| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.05 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.05 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.05 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.05 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.093 | 0.05 |